The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. - Test2 - elhamkhani - TriplyDB

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

http://www.wikidata.org/entity/Q33970656

about

Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials 5-alpha-reductase inhibitors for prostate cancer prevention Finasteride for benign prostatic hyperplasia 5alpha-reductase: history and clinical importance Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer Androgens and prostate disease Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia.Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.Finasteride-induced thrombocytopenia.Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample Pharmacotherapy for benign prostatic hyperplasia.The effect of 5α-reductase-2 deficiency on human fertility Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Treatment of prostate cancer.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.Clinical application of 5alpha-reductase inhibitors.Clinical pearls in men's health.Management of urinary incontinence.Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.Hormonal treatment for prostate cancer.Dutasteride for the treatment of prostate-related conditions.Role of 5α-reductase inhibitors in benign prostatic diseases.Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.

P2860

Q21245273-C1C55104-31A1-4602-A9C6-64F1D63C44D1 Q22252970-945C344A-57BB-4507-BA4E-D026209A17B4 Q24234464-362A9B45-9383-4F9C-80C0-DF221E60D63C Q24546176-67B912A2-6C9E-4E33-856D-B57A7B016111 Q24596101-B55098BD-1D58-46EA-9C9A-573980E17A6D Q24649617-80BF4790-19BE-4687-9C7E-B1BDAAFA3419 Q24658075-FFC40A56-AA98-4722-94DC-57D10278EC82 Q24795452-B4B28FCE-F757-4403-8EBF-AEC1D75E2ADE Q24800317-5358775D-062E-4A91-867F-044C36E89680 Q26750620-6AAC3377-D217-41E1-AF3C-CAC1FEF5BEA4 Q27010093-20A17DE9-3EEB-4106-8AF8-A5E14FA3621B Q28069186-014A5995-F22E-4F69-B04A-B55EFDE36867 Q28077954-BE999FD5-3827-4AAA-8BC9-2F4C57DE4C3D Q28182845-383AF7FC-C92D-4327-A2ED-18EB1FCFEF5A Q28360883-50A313DA-7CFA-4238-BEC5-5ED236C3E5E0 Q28375064-381D4FC5-5B5B-4600-8D85-761EBBDB1C3A Q28379286-54503799-C89F-4B2E-86C5-1830C8A57E87 Q28547130-5040C851-D356-4F34-9842-26AF8298078E Q30408224-E0A5FA22-58D0-4995-B226-98E9A6CB56CB Q32133215-E3F7F81B-906B-42B9-9E9B-9C0A1FB1DAF6 Q32155122-1199D900-A8E3-4B18-A6D7-008506673189 Q33156578-73C70DD0-6296-4EF5-8B59-673891F8D398 Q33343320-51FE262C-F90D-4D3E-9237-06B60485F01E Q33578216-C49242E6-DFFA-4776-BB64-13662B91C4DE Q33608293-0DDCED05-2F88-4B1A-B60B-83A373C796B0 Q33653004-BE013D17-335E-47ED-8FE6-0CB623527F35 Q33658285-0BC51531-1B82-42A1-BF4D-378F6269BA26 Q33668839-5CAC1C98-EF8C-4CC5-9060-574F932D9CDF Q33769561-EE7C8780-EAA5-4CC4-A3BB-EBEC71C15138 Q33797223-B84B7BA7-4C51-4A36-9004-A6E7310F48C1 Q33943526-B9EE7CA8-7E9F-479D-BE8A-5F0ACC827205 Q33951568-E6D08CED-5C49-49CE-85A6-82454EC41A30 Q34022658-8E6956D8-CB99-4318-AA64-94C84131A274 Q34064040-D07223EF-BA2F-410A-95AC-B306009E721C Q34119559-CC59384B-8D13-4B43-82E2-D87A4E0ABC37 Q34167174-01DB1C8D-4860-4D6C-9AF7-D42626A9E06C Q34252953-D990AE62-5049-48AF-875A-E61EFC2C4346 Q34254296-F63F4B4A-755B-4D32-8553-E36EB54C1530 Q34418086-CB0F13F3-17ED-4933-AE53-1888AC765EFF Q34435182-63D25DBD-60F9-4B24-B1BF-90A585BD15E7

P2860

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

http://www.wikidata.org/entity/Q33970656

description

1992 nî lūn-bûn

@nan

1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

The effect of finasteride in m ...... . The Finasteride Study Group.

@ast

The effect of finasteride in m ...... . The Finasteride Study Group.

@en

type

label

The effect of finasteride in m ...... . The Finasteride Study Group.

@ast

The effect of finasteride in m ...... . The Finasteride Study Group.

@en

prefLabel

The effect of finasteride in m ...... . The Finasteride Study Group.

@ast

The effect of finasteride in m ...... . The Finasteride Study Group.

@en

P1433

Q33970656-170AA748-37FB-4ABB-A480-1344A47D35A9

P1476

Q33970656-C9D35949-F611-4FDA-846E-CA0CD6543226

P2093

Q33970656-11564A1D-7026-4603-B6C0-0BE1E8B51AC9

Q33970656-2CF0B3E2-EB1F-46F9-AAA7-6DCECF44280C

Q33970656-4DB60C4E-BC60-4E56-A7B8-3FF122FE3A55

Q33970656-658778BD-00AA-4B02-8AFE-9069618728B3

Q33970656-737ADEDA-7FBB-45B6-8A23-4277FC57A6C4

Q33970656-7C38F36F-88F3-4501-A7A0-5977711D49E5

Q33970656-A0E13E62-0375-4A0A-9F15-018ABC557393

Q33970656-C841D8FB-FFCF-4581-84AB-56F5E9AC7642

Q33970656-D45F656F-0FCE-4CBB-B74C-F88E7D757554

Q33970656-D5883C87-3446-43FD-875F-15587676B51B

P304

Q33970656-FEDF7FEE-8C51-4DB0-9AC9-91D5BE8DF15D

P31

Q33970656-795C0D73-48B5-47A0-A0AA-F5CA788AE46D

P356

Q33970656-00478B23-36B3-400E-B738-09DE39F77EBE

P407

Q33970656-C34F2A89-E913-4541-A4C8-62B381EDF02C

P433

Q33970656-F4668FFA-7226-4B17-9D3C-7C027CFC560B

P478

Q33970656-3A82C29B-40D0-41E4-9940-F0EB1301EED3

P577

Q33970656-829549E3-0F82-408F-A289-9F76CFC7912C

P698

Q33970656-EA6D9FEF-DD65-47F8-B036-88E8FB900A69

P356

NEJM199210223271701

P1433

The New England Journal of Medicine

P1476

The effect of finasteride in m ...... . The Finasteride Study Group.

@en

P2093

Andriole GL

http://www.w3.org/2001/XMLSchema#string

Bracken BR

http://www.w3.org/2001/XMLSchema#string

Bruskewitz RC

http://www.w3.org/2001/XMLSchema#string

Geller J

http://www.w3.org/2001/XMLSchema#string

Gormley GJ

http://www.w3.org/2001/XMLSchema#string

Imperato-McGinley J

http://www.w3.org/2001/XMLSchema#string

McConnell JD

http://www.w3.org/2001/XMLSchema#string

Stoner E

http://www.w3.org/2001/XMLSchema#string

Tenover JS

http://www.w3.org/2001/XMLSchema#string

Walsh PC

http://www.w3.org/2001/XMLSchema#string

P304

1185-1191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199210223271701

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

327

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1383816

http://www.w3.org/2001/XMLSchema#string